---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-043761"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:19:43.175354+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences receives Nasdaq delisting notice after failing to meet equity requirement

## Summary
- Company failed to regain compliance with Nasdaq's minimum $2.5M stockholders' equity by May 13, 2024 deadline.
- Received delist determination letter on May 14, 2024; trading suspension scheduled for May 23, 2024 unless appeal.
- Intends to request a hearing before Nasdaq Hearings Panel, which would stay delisting pending process.
- Also notified of non-compliance with audit committee composition (need three independent directors); cure period until May 2025.
- Common stock (ATNF) and warrants (ATNFW) will continue trading on Nasdaq pending hearing outcome.

## SEC filing metadata
- accession: 0001213900-24-043761
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390024043761/0001213900-24-043761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390024043761/ea0206133-8k_180lifesci.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-043761
- JSON: https://secwatch.observer/filing/0001213900-24-043761.json
- Plain text: https://secwatch.observer/filing/0001213900-24-043761.txt

## Key facts
- Listing & Compliance Notices
  FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: November 15, 2023, the Listing Qualifications department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notified 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) that we did not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b) (the “ Rule ”). Nasdaq provided the Company until January 2, 2024 to submit to Nasdaq a plan to regain compliance. We submitted the plan to regain compliance in a timely manner, and on January 11, 2024, Nasdaq advised the Company that it has determined to grant the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024043761/0001213900-24-043761-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.